Cuppari Lilian, Carvalho Aluízio B, Draibe Sérgio A
Division of Nephrology, Federal University of São Paulo, São Paulo, Brazil.
J Ren Nutr. 2008 Sep;18(5):408-14. doi: 10.1053/j.jrn.2008.05.004.
Vitamin D nutritional status has been poorly investigated in chronic kidney disease (CKD) patients, especially those inhabiting a subtropical area where the sunlight incidence is abundant all year.
The purpose of this study was to evaluate the status of vitamin D and to analyze the relationship of circulating 25-hydroxyvitamin D [25(OH)D] with other serum parameters of mineral metabolism in patients with CKD not yet on dialysis.
This cross-sectional study enrolled 144 nondiabetic CKD patients not yet receiving dialysis (stages 2 to 5 of CKD). Fasting blood samples were obtained for measurements of 25-hydroxyvitamin D [25(OH)D], 1,25-dihydroxyvitamin D [1,25(OH)(2)D], intact parathyroid hormone, phosphorus, and calcium.
In the entire sample, the serum concentration of 25(OH) was 34.3 +/- 18.3 ng/mL (+/-SD unless otherwise noted). A deficiency of vitamin D, i.e., 25(OH)D <15 ng/mL, was found in only one patient. Fifty-seven patients (39.6%) were considered vitamin D-insufficient (16 to 30 ng/mL). The vitamin D-insufficient group contained more females, a higher degree of proteinuria, and a lower serum concentration of 1,25(OH)(2)D. In multiple regression analysis, 25(OH)D was associated positively with 1,25(OH)(2)D, serum calcium, and proteinuria, whereas 1,25(OH)(2)D was associated only with 25(OH)D and phosphorus. The variables associated with intact parathormone were serum phosphorus and creatinine clearance, but not 1,25(OH)(2)D or 25(OH)D.
Despite an elevated prevalence of vitamin D insufficiency, the serum concentration of 25(OH)D was, on average, higher than that found in patients inhabiting higher-latitude regions. This higher serum concentration may have contributed to the differences found in the relationship between vitamin D metabolites and other serum markers of mineral metabolism in our CKD patients.
慢性肾脏病(CKD)患者的维生素D营养状况研究较少,尤其是居住在亚热带地区、全年阳光充足的患者。
本研究旨在评估CKD未透析患者的维生素D状况,并分析循环25-羟维生素D[25(OH)D]与其他矿物质代谢血清参数之间的关系。
本横断面研究纳入了144例未接受透析的非糖尿病CKD患者(CKD 2至5期)。采集空腹血样以测定25-羟维生素D[25(OH)D]、1,25-二羟维生素D[1,25(OH)₂D]、全段甲状旁腺激素、磷和钙。
在整个样本中,25(OH)的血清浓度为34.3±18.3 ng/mL(除非另有说明,均为±标准差)。仅1例患者维生素D缺乏,即25(OH)D<15 ng/mL。57例患者(39.6%)被认为维生素D不足(16至30 ng/mL)。维生素D不足组女性更多,蛋白尿程度更高,1,25(OH)₂D的血清浓度更低。在多元回归分析中,25(OH)D与1,25(OH)₂D、血清钙和蛋白尿呈正相关,而1,25(OH)₂D仅与25(OH)D和磷相关。与全段甲状旁腺激素相关的变量是血清磷和肌酐清除率,而非1,25(OH)₂D或25(OH)D。
尽管维生素D不足的患病率有所升高,但25(OH)D的血清浓度平均高于高纬度地区的患者。这种较高的血清浓度可能导致了我们的CKD患者中维生素D代谢产物与其他矿物质代谢血清标志物之间关系的差异。